Doximity Director Timothy S Cabral Sells 20,200 Shares for $63.68-$64.19 on Aug 15, 2025.

Doximity, Inc. [DOCS] has announced that Director Cabral Timothy S has recently executed a sale of 16,200 shares at a price of $63.68 per share on August 15, 2025. Additionally, he has also sold 3,800 shares at a price of $64.19 per share on the same date.

Doximity, Inc. [DOCS] has announced that Director Timothy S has recently executed a sale of 16,200 shares at a price of $63.68 per share on August 15, 2025. Additionally, he sold 3,800 shares at a price of $64.19 per share on the same date. These transactions occurred following the company's strong second-quarter earnings report, which exceeded market expectations.

The earnings report highlighted robust adoption across Doximity's physician network, with unique active users and prescribers reaching new highs. Both workflow and newsfeed tools saw double-digit growth, while new AI-powered offerings, especially the Scribe ambient notetaking tool, drove engagement. The company's successful upsell season, supported by an expanding product suite and a widely adopted client portal for healthcare customers, was central to its quarterly momentum [1].

Doximity's revenue for the second quarter of 2025 was $145.9 million, beating analyst estimates by 15.2% year-on-year and 4.5% overall. Adjusted EPS was $0.36, 17.2% above estimates, and adjusted operating income was $77.98 million, 53.4% of revenue, beating estimates by 11.6% [1].

The company lifted its full-year revenue guidance to $632 million at the midpoint, up 1.1% from previous estimates, and EBITDA guidance to $345 million at the midpoint. The operating margin improved to 37.4% from 36.4% in the same quarter last year [1].

Market Capitalization: $11.99 billion

The stock price has been volatile following the earnings report. Doximity currently trades at $64.11, up from $58.71 just before the earnings announcement [1].

References:
[1] https://finance.yahoo.com/news/doximity-q2-earnings-call-top-054111724.html